Biogen, Inc. (BIIB)
182.16
+0.18
(+0.10%)
USD |
NASDAQ |
Dec 05, 09:32
Biogen Shareholders Equity (Quarterly): 18.21B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Eli Lilly & Co. | 23.79B |
| Merck & Co., Inc. | 51.85B |
| Pfizer Inc. | 92.80B |
| Stoke Therapeutics, Inc. | 308.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.21B |
| Total Liabilities (Quarterly) | 11.00B |
| Debt to Equity Ratio | 0.3619 |
| Current Ratio | 2.716 |
| Net Debt Paydown Yield | 0.07% |